or Try an Advanced Search...

    Technical Analysis for CELU - Celularity Inc.

    Grade Last Price % Change Price Change
    F 1.44 4.35% 0.06
    CELU closed up 4.35 percent on Friday, November 1, 2024, on 1.42 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical CELU trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 4.35%
    New Downtrend Bearish 4.35%
    Volume Surge Other 4.35%
    Lower Bollinger Band Walk Weakness 4.35%
    New 52 Week Low Weakness 4.35%
    Older End-of-Day Signals for CELU ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Closed about 18 hours ago
    Down 1% about 18 hours ago
    Reversed from Up about 18 hours ago
    Possible NR7 about 19 hours ago
    Possible Inside Day about 19 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CELU Chart by TradingView
    Basic chart:

    Profile

    Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Biotechnology Cancer Biology Immune System Stem Cell Cell Therapy Natural Killer Cell Lymphocytes Therapeutic Solutions

    Is CELU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 23 Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel
    Oct 22 Celularity Provides Corporate Update
    Oct 21 Celularity receives Nasdaq notice, intends to file appeal
    Oct 18 Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
    Oct 16 Celularity acquires Rebound product from Sequence Lifescience
    Oct 16 Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.
    Sep 5 Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
    Aug 28 Celularity Appoints Richard J. Berman to its Board of Directors
    Aug 23 Celularity receives Nasdaq notice regarding late Form 10-Q filing
    Jul 31 Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023
    See more CELU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.97
    52 Week Low 1.3
    Average Volume 27,177
    200-Day Moving Average 3.42
    50-Day Moving Average 2.60
    20-Day Moving Average 2.21
    10-Day Moving Average 1.84
    Average True Range 0.27
    RSI (14) 25.93
    ADX 26.48
    +DI 11.29
    -DI 30.08
    Chandelier Exit (Long, 3 ATRs) 2.12
    Chandelier Exit (Short, 3 ATRs) 2.12
    Upper Bollinger Bands 3.10
    Lower Bollinger Band 1.32
    Percent B (%b) 0.07
    BandWidth 80.45
    MACD Line -0.33
    MACD Signal Line -0.23
    MACD Histogram -0.0947
    Fundamentals Value
    Market Cap 311.62 Million
    Num Shares 216 Million
    EPS -1.03
    Price-to-Earnings (P/E) Ratio -1.40
    Price-to-Sales 6.26
    Price-to-Book 2.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.77
    Resistance 3 (R3) 1.78 1.68 1.72
    Resistance 2 (R2) 1.68 1.60 1.68 1.70
    Resistance 1 (R1) 1.56 1.54 1.51 1.55 1.68
    Pivot Point 1.46 1.46 1.44 1.46 1.46
    Support 1 (S1) 1.34 1.38 1.29 1.33 1.20
    Support 2 (S2) 1.24 1.32 1.24 1.18
    Support 3 (S3) 1.12 1.24 1.17
    Support 4 (S4) 1.11